Literature DB >> 30148058

Case of Scedosporium aurantiacum infection detected in a subcutaneous abscess.

Makoto Kondo1, Hiroyuki Goto1, Keiichi Yamanaka1.   

Abstract

This is the case report of a Scedosporium aurantiacum infection in a subcutaneous abscess. The patient had underlying diabetes and malignant lymphoma. Scedosporium species occur widely in nature and are increasingly recognized as pathologies under specific conditions, such as in immunocompromised hosts.

Entities:  

Keywords:  Diabetes; Immunocompromised; Malignant lymphoma; Scedosporium aurantiacum; Subcutaneous

Year:  2018        PMID: 30148058      PMCID: PMC6105913          DOI: 10.1016/j.mmcr.2018.01.003

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN: 2211-7539


Introduction

Scedosporium species are found widely in nature and cause asymptomatic colonization or localized or disseminated infection following trauma, surgery and immunosuppression. The main sites of Scedosporium aurantiacum (S. aurantiacum) infection are the lungs, ears, and respiratory sinuses [1], [2], [3]. S. aurantiacum is cultured on Sabouraud dextrose agar plates for 5 days at 37 ℃ to achieve sufficient growth. The color of the colonies varies from greyish white to brownish white and produce a light yellow on the reverse of the agar plate. Here, we present the case of S. aurantiacum infection isolated from a subcutaneous abscess in patient with diabetes and malignant lymphoma.

Case

An 82-year old man with diabetes and end-stage malignant lymphoma, who had chosen home medical care treatment with 20 mg/day of prednisolone, experienced a gradual decline in his activities of daily living (ADL)and couldn′t walk around well. He often fell down and injured himself, and came to us complaining of a severe ache on his right hip after falling down (day 0). He was hospitalized for physical examination. After admission, abscess with subcutaneous fluid was observed on his left arm (Fig. 1). The abscess was drained out through a syringe. A filamentous fungus from the subcutaneous fluid was detected on Gram staining (Fig. 2). Laboratory findings revealed white blood cell counts of 5900/μl (normal range: 3900–9800/μl) (high level Neutrophil 83%), CRP levels of 2.14 mg/dl (normal range: 0–0.03 mg/dl), CPK levels of 13 IU/l (normal range: 50–200 IU/L), IgM levels of 7 mg/dl (normal range: 35–220 mg/dl), IgG levels of 707 mg/dl (normal range: 870–1700 mg/dl), HbA1c levels of 7.6% (normal range: 4.6–6.2%), and (1→3)- β-D glucan levels of 177 pg/ml (normal range: 0–20 pg/ml). X-ray scans of his chest and left arm were normal. The culture plate showed a dark black colony in a potato dextrose agar medium and a whitish colony in the CHROMager Candida medium on one surface at 25 °C for 7 days (day 7) (Fig. 3). Moreover, both agars showed green colonies on the opposite sides (Fig. 3). DNA extracted from the colony was processed by PCR using the Fungal rDNA (ITS1) PCR Kit Fast (Takara Bio, Tokyo, Japan) (Fig. 4). The resulting sequence was compared with sequences of type strains reported in GenBank using the Basic Local Alignment Search Tool (BLAST) algorithm. The PCR products were confirmed to be of S. aurantiacum of ITS1 identified at 100% with the type strain of the species CBS 117423. We performed skin puncture of subcutaneous abscess twice, and skin symptom had been recovered without using antifungal drugs.
Fig. 1

The left arm presented with a wide-spread subcutaneous abscess under eczematic changes with a yellow crust.

Fig. 2

The hyphal structure with septum and hyphal terminus formed conidia-bearing hyphae.

Fig. 3

The front cover showed dark black colony in potato dextrose agar medium and whitish colony in the CHROMager Candida medium at 25 °C for 7 days. Both agars showed green colonies on the opposite sides.

Fig. 4

Lane1: PCR product amplified from DNA of the colony cultured from subcutaneous fluid sample. Lane2: Double-checked PCR products from the same samples as lane1. Lane4: PCR product amplified from Candida albicans DNA as the negative control. Lane5: The negative control included in Fungal rDNA (ITS1) PCR Kit Fast.

The left arm presented with a wide-spread subcutaneous abscess under eczematic changes with a yellow crust. The hyphal structure with septum and hyphal terminus formed conidia-bearing hyphae. The front cover showed dark black colony in potato dextrose agar medium and whitish colony in the CHROMager Candida medium at 25 °C for 7 days. Both agars showed green colonies on the opposite sides. Lane1: PCR product amplified from DNA of the colony cultured from subcutaneous fluid sample. Lane2: Double-checked PCR products from the same samples as lane1. Lane4: PCR product amplified from Candida albicans DNA as the negative control. Lane5: The negative control included in Fungal rDNA (ITS1) PCR Kit Fast.

Discussion

Scedosporium species are widely distributed in environmental sources and have been increasingly recognized as pathogens in immunocompromised hosts. Scedosporium species-related infections have been reported mainly in Australia [1]. However, S. aurantiacum is a rare fungus, and this was not detected in a review of 107 cases of Scedosporium species infections [4]. The lungs, ears, and sinuses have been reported to be the primary sites of S. aurantiacum infection [1], [2], [3]. However, skin infections have only been detected by other Scedosporium species, such as S. prolificans [4], [5]. We had speculated bacterial infection from thick fluid and the color of subcutaneous drainage. We reached the diagnosis by fungal culture. The patients infected with S. aurantiacum had a history of stem cell transplantation, leukemia, neutropenia, diabetes, etc [1], [4]. In the current case, the patient had been treated for diabetes and malignant lymphoma and has not fully recovered from the S. aurantiacum infection. We believe the soil in the patient's house garden was the source of the infection because he reported falling there many times. This is the first report of S. aurantiacum infection detected in a subcutaneous abscess. Our finding should warn physicians of the need to identify the species in Scedosporium infections to determine the most appropriate anti-fungal drugs considering that sensitivities for S. aurantiacum and S.prolificans infection drugs are different [1].
  5 in total

Review 1.  Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan.

Authors:  Yutaka Nakamura; Naomi Suzuki; Yoshio Nakajima; Yu Utsumi; Okinori Murata; Hiromi Nagashima; Heisuke Saito; Nobuhito Sasaki; Itaru Fujimura; Yoshinobu Ogino; Kanako Kato; Yasuo Terayama; Shinya Miyamoto; Kyoko Yarita; Katsuhiko Kamei; Toshihide Nakadate; Shigeatsu Endo; Kazutoshi Shibuya; Kohei Yamauchi
Journal:  Respir Investig       Date:  2013-08-20

2.  Fatal Scedosporium prolificans infection in a paediatric patient with acute lymphoblastic leukaemia.

Authors:  Min J Song; Jang H Lee; Nam Y Lee
Journal:  Mycoses       Date:  2011-01       Impact factor: 4.377

3.  Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.

Authors:  Peter Troke; Koldo Aguirrebengoa; Carmen Arteaga; David Ellis; Christopher H Heath; Irja Lutsar; Montserrat Rovira; Quoc Nguyen; Monica Slavin; Sharon C A Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

4.  Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.

Authors:  C H Heath; M A Slavin; T C Sorrell; R Handke; A Harun; M Phillips; Q Nguyen; L Delhaes; D Ellis; W Meyer; S C A Chen
Journal:  Clin Microbiol Infect       Date:  2009-06-22       Impact factor: 8.067

5.  Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs.

Authors:  Jashanpreet Kaur; Shu Yao Duan; Lea A I Vaas; Anahit Penesyan; Wieland Meyer; Ian T Paulsen; Helena Nevalainen
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

  5 in total
  2 in total

1.  Multilocus Sequence Typing Reveals Extensive Genetic Diversity of the Emerging Fungal Pathogen Scedosporium aurantiacum.

Authors:  Azian Harun; Alex Kan; Katharina Schwabenbauer; Felix Gilgado; Haybrig Perdomo; Carolina Firacative; Heidemarie Losert; Sarimah Abdullah; Sandrine Giraud; Josef Kaltseis; Mark Fraser; Walter Buzina; Michaela Lackner; Christopher C Blyth; Ian Arthur; Johannes Rainer; José F Cano Lira; Josep Guarro Artigas; Kathrin Tintelnot; Monica A Slavin; Christopher H Heath; Jean-Philippe Bouchara; Sharon C A Chen; Wieland Meyer
Journal:  Front Cell Infect Microbiol       Date:  2021-12-27       Impact factor: 5.293

2.  In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis.

Authors:  S Seyedmousavi; Y C Chang; J H Youn; D Law; M Birch; J H Rex; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2021-07-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.